Habs M, Deutsch-Wenzel R, Preussmann R, Schmähl D
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978 May 31;91(2):183-8. doi: 10.1007/BF00284024.
The oral acute LD50 of N-Methyl-N'-Nitro-N-Nitrosoguanidine (MNNG) in a 10% aqueous solution of dimethylsulfoxide (DMSO) amounted to approximately 90 mg/kg. After single oral application of 50 mg/kg (group I), 75 mg/kg (group II) and 100 mg/kg (group III) of MNNG in a 10% aqueous solution of DMSO, generalized papillomatoses of the forestomach were found in all BD-VI rats after a test period of 500 days. Squamous cell carcinomas could be detected in 7/24 (21%) rats in group I, in 12/26 (46%) in group II and in 7/23 (30%) in group III). Benign adenomatous dysplasia of the glandular stomach was diagnosed in 2 rats (8%) of group I, in 1 animal (4%) of group II and in 12 rats (52%) of group III. Adenocarcinomas of the glandular stomach were induced in 1 animal (4%) of both group I and II and in 8 rats (35%) of group III. 20--30% of the animals treated with MNNG also showed degenerative cystic alterations in the liver with bile-duct proliferation.
在含10%二甲基亚砜(DMSO)的水溶液中,N-甲基-N'-硝基-N-亚硝基胍(MNNG)的经口急性半数致死量(LD50)约为90毫克/千克。在以含10%DMSO的水溶液形式单次经口给予50毫克/千克(第一组)、75毫克/千克(第二组)和100毫克/千克(第三组)的MNNG后,在500天的试验期后,所有BD-VI大鼠均出现前胃广泛性乳头瘤病。在第一组的24只大鼠中有7只(21%)、第二组的26只大鼠中有12只(46%)以及第三组的23只大鼠中有7只(30%)检测到鳞状细胞癌。第一组有2只大鼠(8%)、第二组有1只动物(4%)以及第三组有12只大鼠(52%)被诊断为腺胃良性腺瘤样发育异常。第一组和第二组各有1只动物(4%)以及第三组有8只大鼠(35%)诱发了腺胃癌。用MNNG处理的动物中,20% - 30%还表现出肝脏的退行性囊性改变并伴有胆管增生。